Showing 1 - 10 results of 10 for search 'Louis B Hersh', query time: 0.03s Refine Results
  1. 1
    A monomeric variant of insulin degrading enzyme (IDE) loses its regulatory properties.

    A monomeric variant of insulin degrading enzyme (IDE) loses its regulatory properties. by Eun Suk Song, David W Rodgers, Louis B Hersh

    Published 2010-03-01
    Get full text
    Article
  2. 2
    Active site mutations change the cleavage specificity of neprilysin.

    Active site mutations change the cleavage specificity of neprilysin. by Travis Sexton, Lisa J Hitchcook, David W Rodgers, Luke H Bradley, Louis B Hersh

    Published 2012-01-01
    Get full text
    Article
  3. 3
    The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells.

    The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells. by Hanjun Guan, K Martin Chow, Eunsuk Song, Nirmal Verma, Florin Despa, Louis B Hersh

    Published 2015-01-01
    Get full text
    Article
  4. 4
    Structure of puromycin-sensitive aminopeptidase and polyglutamine binding.

    Structure of puromycin-sensitive aminopeptidase and polyglutamine binding. by Sowmya Madabushi, K Martin Chow, Eun Suk Song, Anwesha Goswami, Louis B Hersh, David W Rodgers

    Published 2023-01-01
    Get full text
    Article
  5. 5
    Cysteine 904 is required for maximal insulin degrading enzyme activity and polyanion activation.

    Cysteine 904 is required for maximal insulin degrading enzyme activity and polyanion activation. by Eun Suk Song, Manana Melikishvili, Michael G Fried, Maria A Juliano, Luiz Juliano, David W Rodgers, Louis B Hersh

    Published 2012-01-01
    Get full text
    Article
  6. 6
    Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3

    Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding pa... by Caroline N. Smith, Kyle Kihn, Zachary A. Williamson, K. Martin Chow, Louis B. Hersh, Konstantin V. Korotkov, Daniel Deredge, Jessica S. Blackburn

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3.

    Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding pa... by Caroline N Smith, Kyle Kihn, Zachary A Williamson, K Martin Chow, Louis B Hersh, Konstantin V Korotkov, Daniel Deredge, Jessica S Blackburn

    Published 2023-01-01
    Get full text
    Article
  8. 8
    Identification of the allosteric regulatory site of insulysin.

    Identification of the allosteric regulatory site of insulysin. by Nicholas Noinaj, Sonia K Bhasin, Eun Suk Song, Kirsten E Scoggin, Maria A Juliano, Luiz Juliano, Louis B Hersh, David W Rodgers

    Published 2011-01-01
    Get full text
    Article
  9. 9
    An Extended Polyanion Activation Surface in Insulin Degrading Enzyme.

    An Extended Polyanion Activation Surface in Insulin Degrading Enzyme. by Eun Suk Song, Mehmet Ozbil, Tingting Zhang, Michael Sheetz, David Lee, Danny Tran, Sheng Li, Rajeev Prabhakar, Louis B Hersh, David W Rodgers

    Published 2015-01-01
    Get full text
    Article
  10. 10
    Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes

    Aerosol capture and coronavirus spike protein deactivation by enzyme functionalized antiviral membranes by Rollie Mills, Ronald J. Vogler, Matthew Bernard, Jacob Concolino, Louis B. Hersh, Yinan Wei, Jeffrey Todd Hastings, Thomas Dziubla, Kevin C. Baldridge, Dibakar Bhattacharyya

    Published 2022-05-01
    Get full text
    Article

Search Tools: